Publications Database

Rossignol D. A. , Frye R. E. (2012)

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.

Molecular Psychiatry

17(3), pp. 290-314.

Read Abstract (New Window)

Rossignol D. A. (2009)

Novel and emerging treatments for autism spectrum disorders: a systematic review.

Annals of Clinical Psychiatry

21(4), pp. 213-236

Read Abstract (New Window)

Rossignol D. A. , Frye R. E. (2014)

The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review.

Frontier in Pediatrics

August, 2

Read Abstract (New Window) Read Full (New Window)

Rueda J. et al. (2011)

Folic acid for fragile X syndrome.

Cochrane Database of Systematic Reviews

Read Abstract (New Window)

Ruxton C. et al. (2004)

The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence.

Journal of Human Nutrition and Dietetics

17(5), pp. 449-459

Read Abstract (New Window)

Saad K. et al. (2015)

A randomized, placebo-controlled trial of digestive enzymes in children with autism spectrum disorders.

Clinical Psychopharmacology and Neuroscience

13(2), pp. 188-193.

Read Abstract (New Window) Read Full (New Window)

Saad K. et al.

Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder.

Journal of Child Psychology and Psychiatry

Read Abstract (New Window)

Sakulchit T. , Ladish C. , Goldman R. D. (2017)

Hyperbaric oxygen therapy for children with autism spectrum disorder.

Canadian Family Physician

June, 63(6),

Read Abstract (New Window) Read Full (New Window)

Salvador M. et al. (2014)

Evidence of the gluten-free and casein-free diet in autism spectrum disorders: A systematic review.

Journal of Child Neurology

December, 29(12), pp. 1718-1727.

Read Abstract (New Window)

Sampanthavivat M. et al. (2012)

Hyperbaric oxygen in the treatment of childhood autism: a randomised controlled trial.

Diving Hyperbaric Medicine

42(3), pp.28-33.

Read Abstract (New Window)

Sandler A. D. et al. (1999)

Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.

New England Journal of Medicine

341(24), pp. 1801-1806

Read Abstract (New Window) Read Full (New Window)

Semon B. (1991)

Reversing autism: The story behind feast without yeast.

Wisconsin: Wisconsin Institute of Nutrition

Read Full (New Window)

Senel H. G. (2010)

Parents' views and experiences about complementary and alternative medicine treatments for their children with autistic spectrum disorder.

Journal of Autism and Developmental Disorders

April, 40(4), pp. 494-503.

Read Abstract (New Window)

Shaaban S. Y. et al.

The role of probiotics in children with autism spectrum disorder: A prospective, open-label study.

Nutritional Neuroscience

Read Abstract (New Window)

Sharma A. et al. (2013)

Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study.

Stem Cells International

Read Abstract (New Window) Read Full (New Window)

Sharpe K. , Di Pietro N. C. , Illes J. (2016)

In the know and in the news: How science and the media communicate about stem cells, autism and cerebral palsy.

Stem Cell Reviews and Reports

February, 12(2), pp. 1-7.

Read Abstract (New Window)

Shattock P. (1989)

Diet.

Communication

pp. 22-25

Shaw W. (2002)

Biological treatments for autism and PDD.

Lenexa, KS: Great Plains Laboratory, Inc.

Sheppard K. et al.

Effect of omega-3 and -6 supplementation on language in preterm toddlers exhibiting autism spectrum disorder symptoms.

Journal of Autism and Developmental Disorders

Read Abstract (New Window)

Singh K. et al. (2014)

Sulforaphane treatment of autism spectrum disorder (ASD).

Proceedings of the National Academy of Science U S A

111(43), pp. 15550-15555.

Read Abstract (New Window) Read Full (New Window)